IN181358B - - Google Patents

Info

Publication number
IN181358B
IN181358B IN262CA1996A IN181358B IN 181358 B IN181358 B IN 181358B IN 262CA1996 A IN262CA1996 A IN 262CA1996A IN 181358 B IN181358 B IN 181358B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Alvaro Morales
Stanley J Alkemade
Original Assignee
Bioniche Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/388,038 external-priority patent/US5591724A/en
Application filed by Bioniche Inc filed Critical Bioniche Inc
Publication of IN181358B publication Critical patent/IN181358B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
IN262CA1996 1995-02-14 1996-02-13 IN181358B (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/388,038 US5591724A (en) 1995-02-14 1995-02-14 Method for treating the urinary bladder and associated structures using hyaluronic acid
US59101596A 1996-02-08 1996-02-08

Publications (1)

Publication Number Publication Date
IN181358B true IN181358B (ja) 1998-05-30

Family

ID=27012116

Family Applications (1)

Application Number Title Priority Date Filing Date
IN262CA1996 IN181358B (ja) 1995-02-14 1996-02-13

Country Status (20)

Country Link
US (1) US5888986A (ja)
EP (1) EP0813417B1 (ja)
JP (1) JP4354528B2 (ja)
KR (1) KR100268660B1 (ja)
CN (1) CN1181016A (ja)
AT (1) ATE247476T1 (ja)
AU (1) AU705289B2 (ja)
BR (1) BR9607601A (ja)
CA (1) CA2203621C (ja)
CZ (1) CZ288218B6 (ja)
DE (1) DE69629553T2 (ja)
DK (1) DK0813417T3 (ja)
ES (1) ES2205013T3 (ja)
HU (1) HUP9800467A3 (ja)
IN (1) IN181358B (ja)
NO (1) NO315842B1 (ja)
NZ (1) NZ300903A (ja)
PT (1) PT813417E (ja)
TR (1) TR199700782T1 (ja)
WO (1) WO1996025168A1 (ja)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998017320A1 (en) * 1991-07-03 1998-04-30 Hyal Pharmaceutical Corporation Use of hyaluronan in gene therapy
CA2247389C (en) * 1996-12-27 2009-11-24 Seikagaku Corporation Agent for treatment of bladder troubles
US6548487B2 (en) 1996-12-27 2003-04-15 Seikagaku Corporation Agent for treatment of bladder troubles
DK1124546T3 (da) * 1998-10-22 2004-08-09 Bioniche Life Sciences Inc Anvendelse af hyaluronsyre til behandling af strålingsfremkaldt cystitis
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
CA2393808A1 (en) * 1999-12-13 2001-06-21 Bioniche Life Sciences Inc. Anti-cancer synthetic oligonucleotides
CA2395493C (en) * 1999-12-28 2010-06-22 Bioniche Life Sciences Inc. Hyaluronic acid in the treatment of cancer
US7504387B2 (en) * 2002-10-16 2009-03-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
US20040161476A1 (en) 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
KR20140002082A (ko) * 2005-01-14 2014-01-07 유리젠, 인코포레이티드 하부 요로 장애 치료용 키트 및 개선된 조성물
DE102006060953A1 (de) 2006-12-12 2008-08-07 Farco-Pharma Gmbh Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
US8343942B2 (en) * 2008-04-04 2013-01-01 University Of Utah Research Foundation Methods for treating interstitial cystitis
TWI516269B (zh) 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物
TWI383796B (zh) 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
HUP0900717A3 (en) * 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
US8575130B2 (en) * 2010-01-04 2013-11-05 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
US20110166098A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
US8722644B2 (en) 2010-01-04 2014-05-13 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US8449512B2 (en) 2010-04-09 2013-05-28 Davinci Biomedical Research Products Inc. Stoma stabilitating device and method
US9029347B2 (en) 2010-08-05 2015-05-12 Holy Stone Healthcare Co., Ltd. Method and mixture for treating and preventing inflammatory bowel disease
EP2545925B1 (en) 2011-07-12 2018-02-14 Holy Stone Healthcare Co.,Ltd. Compositions comprising hyaluronic acid for treating and preventing mucosa related diseases
ITMI20111732A1 (it) * 2011-09-27 2013-03-28 Bsdpharma Srl Formulazioni farmaceutiche per la riduzione della sensibilizzazione crociata tra colon-retto ed il distretto urogenitale con mezzi non-farmacologici.
RU2519010C1 (ru) * 2013-03-20 2014-06-10 Общество с ограниченной ответственностью "КОЛЕТЕКС" Композиция для лечения цистита
WO2015018461A1 (fr) 2013-08-09 2015-02-12 Genbiotech Compositions therapeutiques comprenant d'acide hyaluronique
CN103655601B (zh) * 2013-12-31 2019-10-25 上海建华精细生物制品有限公司 一种用于膀胱灌洗的组合物
CN103861091B (zh) * 2014-03-20 2016-04-27 辽宁亿灵科创生物医药科技有限公司 治疗膀胱炎的药物组合物
US20170189564A9 (en) * 2014-04-03 2017-07-06 Lipella Pharmaceuticals, Inc. Systems and methods of detecting interstitial cystitis
RU2557949C1 (ru) * 2014-08-14 2015-07-27 Общество с ограниченной ответственностью "КОЛЕТЕКС" Способ лечения лучевого и интерстициального цистита
EP3400951B1 (de) * 2017-05-12 2019-12-11 Farco-Pharma GmbH Blaseninstillationszusammensetzung enthaltend chondoitinsulfat (4,5 mg/ml), hyaluronsäure (16 mg/ml) und phosphatpuffer (ph 6,1 bis 7,9) mit erhöhter lagerstabiliät zur behandlung von cystitis

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4296104A (en) * 1979-08-30 1981-10-20 Herschler R J Therapeutic dimethyl sulfoxide composition and methods of use
US4302577A (en) * 1979-10-05 1981-11-24 Biomed Research Inc. Process for preparing CSA or CSC
US5180715A (en) * 1980-11-17 1993-01-19 The Regents Of The University Of California Irrigation of internal bladder surfaces in mammals with sodium pentosanpolysulfate
DE3118588C2 (de) * 1981-05-11 1983-07-07 Luitpold-Werk, Chemisch-Pharmazeutische Fabrik, 8000 München Verfahren zur Herstellung eines injizierbaren hochreinen Chondroitinpolysulfates, hiernach erhältliches Produkt und pharmazeutische Zusammensetzung
US4640912A (en) * 1983-06-09 1987-02-03 Hausman Marvin S Administration of "active" chondroitin sulfate A and "active" chondroitin sulfate C or mixtures thereof to mammals including humans
US4711780A (en) * 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
US4966890A (en) * 1986-04-04 1990-10-30 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4820693A (en) * 1986-05-22 1989-04-11 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4879282A (en) * 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules
US5037810A (en) * 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules
DE69329407T2 (de) * 1992-06-02 2001-05-03 Bard Inc C R Verfahren und Implantatvorrichtung für Langzeitwirkstoffabgabe
DE784487T1 (de) * 1993-03-19 1999-11-04 Q Med Ab Uppsala Ein präparat und ein verfahren zur gewebevermehrung

Also Published As

Publication number Publication date
JP4354528B2 (ja) 2009-10-28
ATE247476T1 (de) 2003-09-15
MX9706182A (es) 1998-07-31
CA2203621A1 (en) 1996-08-22
PT813417E (pt) 2003-12-31
KR19980702251A (ko) 1998-07-15
AU705289B2 (en) 1999-05-20
NO973732L (no) 1997-10-10
CZ288218B6 (en) 2001-05-16
HUP9800467A2 (hu) 1998-06-29
AU4617996A (en) 1996-09-04
NZ300903A (en) 1999-07-29
NO973732D0 (no) 1997-08-13
KR100268660B1 (ko) 2000-10-16
US5888986A (en) 1999-03-30
DE69629553T2 (de) 2004-06-17
ES2205013T3 (es) 2004-05-01
NO315842B1 (no) 2003-11-03
BR9607601A (pt) 1999-09-14
CN1181016A (zh) 1998-05-06
DK0813417T3 (da) 2003-11-03
DE69629553D1 (de) 2003-09-25
HUP9800467A3 (en) 1999-01-28
TR199700782T1 (xx) 1998-03-21
EP0813417B1 (en) 2003-08-20
WO1996025168A1 (en) 1996-08-22
CA2203621C (en) 1998-04-28
CZ257497A3 (cs) 1998-01-14
JPH10513476A (ja) 1998-12-22
EP0813417A1 (en) 1997-12-29

Similar Documents

Publication Publication Date Title
DE69638352D1 (ja)
DE69637714D1 (ja)
BR122012014331A2 (ja)
BRPI9612258B1 (ja)
BRPI9612138B1 (ja)
EP0724005A3 (ja)
ECSDI950232S (ja)
DK143195A (ja)
CH0741373H1 (ja)
DK0727898T3 (ja)
BR7501503U (ja)
BR7502120U (ja)
ECSDI950233S (ja)
ECSDI950231S (ja)
ECSDI950230S (ja)
ECSDI950229S (ja)
ECSDI950223S (ja)
DK126096A (ja)
CN3033771S (ja)
CN3036463S (ja)
CN3032568S (ja)
CN3032692S (ja)
CN3033225S (ja)
CN3033635S (ja)
CN3031926S (ja)